High performance anion exchange chromatography purification of probiotic bacterial extracellular vesicles enhances purity and anti_inflammatory efficacy

Loading...
Thumbnail Image

Publication or External Link

External Link to Data Files

Date

Advisor

Citation

Pirolli, N. H., Reus, L. S. C., Mamczarz, Z., Khan, S., Bentley, W. E., Jay, S. M., Pirolli, N. H., Reus, L. S. C., Mamczarz, Z., Khan, S., Bentley, W. E., & Jay, S. M. (2023). High performance anion exchange chromatography purification of probiotic bacterial extracellular vesicles enhances purity and anti_inflammatory efficacy. Biotechnology and Bioengineering, 120(11), 3368�3380. https://doi.org/10.1002/bit.28522

Abstract

Abstract Bacterial extracellular vesicles (BEVs), including outer membrane vesicles, have emerged as a promising new class of vaccines and therapeutics to treat cancer and inflammatory diseases, among other applications. However, clinical translation of BEVs is hindered by a current lack of scalable and efficient purification methods. Here, we address downstream BEV biomanufacturing limitations by developing a method for orthogonal size_ and charge_based BEV enrichment using tangential flow filtration (TFF) in tandem with high performance anion exchange chromatography (HPAEC). The data show that size_based separation coisolated protein contaminants, whereas size_based TFF with charged_based HPAEC dramatically improved purity of BEVs produced by probiotic Gram_negative Escherichia coli and Gram_positive lactic acid bacteria (LAB). Escherichia coli BEV purity was quantified using established biochemical markers while improved LAB BEV purity was assessed via observed potentiation of anti_inflammatory bioactivity. Overall, this work establishes orthogonal TFF + HPAEC as a scalable and efficient method for BEV purification that holds promise for future large_scale biomanufacturing of therapeutic BEV products.

Notes

Rights

Attribution-NonCommercial 4.0 International
https://creativecommons.org/licenses/by-nc/4.0/